Drug Approval Drug Approval Process Vaccine Approval Tobacco Control E-Cigarettes Tobacco Products Medical Device Approval Drug Safety Food Safety Regulations Consumer Protection E-cigarettes Vaccine Approval Process Public Health Clinical Trials Cosmetic Safety Food Regulations Food Safety Food Safety Oversight Sunscreen Approval Warning Vaping Products Consumer Safety Public Health Policy Cosmetic Regulations Manufacturing Standards Policy Changes Recall Animal Drugs New Drug Application Food and Drug Administration Import Restrictions Black Box Warning Product Warning Consent Decree Allergen Thresholds Food Safety Modernization Act (FSMA) USDA Mifepristone Recommendations Advisory Committee Product Labeling Clinical Holds Healthcare Policy Food Safety Standards Food Safety Policies Food Additives Health Recommendations E-Cigarette Regulation E-cigarette Regulation Guidelines Import Alerts Warnings Kratom Products Drug Facility Oversight Cosmetics Drug Production Biologics License Application Drug Advertising Nonprescription Drugs Drug Labeling Drug Recalls Sunscreen Regulation Vaccine Oversight Food Dyes Recall Notice Advisory Meeting Advisory Committees Product Recall Product Authorization E-cigarette Authorization Drug Shortages Flavored Vaping Products Tobacco Regulation Drug Classification Dietary Supplement Regulation Recalls Tobacco Regulations Hearing Aids Substance Control FDA Inspections Warning Letters E-cigarette Policy Biologic License Application Biologics Public Policy Food Regulation Medical Approval Product Oversight Health Regulations
FDA could issue a U.S. decision by March 28 under a faster review timeline, according to Reuters.
